Tissue Bank for Pulmonary Diseases

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Boston Children’s Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Harvard University
Information provided by:
Boston Children’s Hospital
ClinicalTrials.gov Identifier:
NCT00546962
First received: October 17, 2007
Last updated: May 12, 2011
Last verified: May 2011
  Purpose
The aim of this research study is to collect and store the specimens that are left over after patients undergo tests ordered by their physicians. These specimens will be used at a later time by researchers in the Pulmonary Division to develop a better understanding of pulmonary diseases or for the development of new treatments. Typical research studies that will be conducted on the stored tissue, fluid, or bacteria from the patient sample involve obtaining bacterial cultures, measurement of inflammatory markers, and examination of the characteristics of the tissue. Other similar tests may be done in the future; however, these tests have not all been determined at this time. It is important to note that no genetic testing will be performed on any samples that are obtained as part of this protocol.

Condition
Cystic Fibrosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Tissue Bank for Pulmonary Diseases

Resource links provided by NLM:


Further study details as provided by Boston Children’s Hospital:

Estimated Enrollment: 400
Study Start Date: April 1999
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cystic Fibrosis Patients, Pulmonary Patients
Criteria

Inclusion Criteria:

  • Open
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00546962

Locations
United States, Massachusetts
Children's Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact: Ashish George    617-355-6665    ashish.george@childrens.harvard.edu   
Sponsors and Collaborators
Boston Children’s Hospital
Harvard University
Investigators
Principal Investigator: Thomas Martin, MD Boston Children’s Hospital
  More Information

Responsible Party: Thomas Martin, MD, Childrens Hospital Boston
ClinicalTrials.gov Identifier: NCT00546962     History of Changes
Other Study ID Numbers: 05-02-014R 
Study First Received: October 17, 2007
Last Updated: May 12, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Lung Diseases
Cystic Fibrosis
Respiratory Tract Diseases
Pancreatic Diseases
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on August 25, 2016